Cerebral ammonia metabolism was studied in five control subjects and five patients with severe liver disease exhibiting minimal hepatic encephalopathy. The arterial ammonia concentration in the control subjects was 30 ± 7 /l-mollL (mean ± SD) and 55 ± 13 /l-mollL in the patients (p < 0.01). In the normal subjects. the whole brain values for cerebral blood flow. cerebral metabolic rate for ammonia. and the permeability-surface area product for ammonia were 0.58 ± 0.12 ml g-I min-I, 0.35 ± 0. 15 /l-mol 100 g--I min-I, and 0.13 ± 0.03 ml g-I min -I. respectively. In the patients, the respective val ues were 0.46 ± 0. 16 ml g -I min -I (not different from control), 0.91 ± 0.36 /l-mol 100 g-I min -I (p < 0.025), Abbreviations used: aPS, apparent permeability-surface area product; PET, positron emission tomography; rCMRA, regional cerebral metabolic rate of ammonia.
Hepatic encephalopathy is the result of a com plex physiological and neurochemical disruption.
Theories concerning the relative roles of true and false neurotransmitters, most notably benzodiaze pine-like ligands, postsynaptic receptor proteins, mercaptans, short-chain fatty acids, and ammonia, have been advanced to explain the pathogenesis of the syndrome (Lockwood, 1987) . No single hypoth esis accounts successfully for the development of encephalopathy in all patients (Lockwood, 1987) .
Ammonia is the toxin that is the most studied and most clearly implicated in the pathogenesis of the disorder (Phear et aI. , 1955; Sherlock, 1958; Walker and Schenker, 1970; Duffy et aI. , 1974; Lockwood et aI. , 1979; Butterworth et aI. , 1987; Lockwood, 1987) . However, some comatose patients have nor mal, or near normal, arterial ammonia levels (Sher-and 0.22 ± 0.07 ml g -I min -I (p < 0.05). The increased permeability-surface area product of the blood-brain bar rier permits ammonia to diffuse across the blood-brain barrier into the brain more freely than normal. This may cause ammonia-induced encephalopathy even though ar terial ammonia levels are normal or near normal and ex plain the emergence of toxin hypersensiti vity as liver dis ease progresses. Greater emphasis on early detection of encephalopathy and aggressive treatment of minimal hy perammonemia may retard the development of ammonia induced complications of severe liver disease. Key Words: Hepatic encephalopathy-Ammonia-Blood brain barrier-Positron emission tomography. lock, 1958). This has raised doubt about the impor tance of ammonia in coma production.
We have used positron emission tomography (PET) to investigate cerebral ammonia metabolism in patients with severe liver disease and in a group of normal controls. We report a significant increase in the cerebral metabolic rate for ammonia in the patients with liver disease that is associated with an increase in the cerebral extraction of ammonia and an increase in the apparent permeability-surface area (aPS) product. The resulting increase in the ease with which ammonia moves into the brain from the blood may account for the development of toxin hypersensitivity and explain the presence of cere bral dysfunction in patients with near-normal arte rial ammonia concentrations. A preliminary report of this work has been presented in abstract form (Lockwood and Yap, 1989) .
METHODS

Patient selection
Patients and controls were enrolled in this study using informed consent guidelines and protocols approved by the University of Texas Health Science Center at Hous-ton Committee for the Protection of Human Subjects in Research. Control subjects were free of liver and nervous system disease, and were receiving no medications with central actions. All patients were hospitalized because of an acute complication of liver disease documented by bi opsy-proven cirrhosis; elevation of serum transaminases; hyperbilirubinemia; hypoalbuminemia; prolongation of the prothrombin time; portal hypertension, manifested by radiographically or endoscopically demonstrable esopha geal varices, frequently associated with a recent hemor rhage or ascites; or encephalopathy. Potential subjects with acute infections, diabetes mellitus, hepatorenal syndrome, or other nonhepatic diseases were excluded. Subjects were examined by a neurologist on the day of the study.
General procedures
All subjects were scanned with their eyes open with the head immobilized in a holder to maintain head position between scans. Images were recorded in planes parallel to the canthomeatal lines. The radial artery was catheter ized and irrigated continuously with 0.9% heparinized sa line with an IntraFlo system (Sorensen, Salt Lake City, Utah, U.S.A.). Radiopharmaceuticals were given intra venously in the opposite arm.
[13N]ammonia, essentially carrier free (no carrier added), and e50]water were prepared using methods that produce sterile, pyrogen-free radiopharmaceuticals, in accord with Federal Drug Administration regulations (West and Dollery. 1961; Krizek et al.. 1977) .
Brain images were recorded using the University of Texas positron camera (Mullani et aI., 1982 (Mullani et aI., , 1984 . A brief transmission scan was performed to define the boundary of the head in each image plane to make a sub sequent theoretical correction for gamma photon attenu ation by the brain, assuming a uniform head density for each subject. The camera and well counter (used to mea sure the isotope content of blood samples) were cali brated on the day of each study.
Physiological measurements
The regional cerebral blood flow (rCBF) was measured on a pixel-by-pixel basis, using the computational ap proach described by Ginsberg, Howard, and associates with the decay constant for 150 included explicitly in the operational equation (Ginsberg et aI., 1982; Howard et aI., 1983) utilizing an intravenous bolus injection of 1.48
x 109 Bq (40 mCi) of rI50]water. Appropriate decay cor rections were made for delays in counting arterial blood samples and for the difference between the arrival time of the tracer at the radial artery catheter and the brain .
Ammonia metabolism studies began about 15 min after the CBF study and decay of the 150 (half-life of 123 s). The regional cerebral metabolic rate for ammonia (rCMRA) was computed as previously described (Lock wood et a!., 1979 (Lock wood et a!., , 1984 For each pixel, the rCBF and rCMRA values were used to compute the fractional extraction of ammonia (E), and the capillary aPS product with the mathematical equa tions and physiological assumptions described previously (Lockwood et a!., 1984) . Briefly, the equation used was
where a and v represent the concentration of ammonia in the arterial supply and venous drainage for each pixel, respectively, assuming that the value of a is the same for each pixel. Then, by definition,
From the Renkin-Crone capillary model (Lockwood et aI., 1984) , PS is computed as
where In indicates the computation of the natural loga rithm of the quantity (1 -E).
Regions of interest were drawn on the CBF images and included the following regions from the right and left sides of the brain: in a plane through the thalamus, the frontal, temporal, parietal, and visual cortex, thalamus, and cau date nucleus; in a separate slice, the cerebellar cortex; and in a third slice, the centrum semiovale. Whole-slice data values were determined for the second image listed above. These regions were projected on rCMRA, E, and aPS product images and values were extracted.
Values from the right and left sides of the brain were averaged and tabulated. Differences in whole-slice vari able values were determined with a two-tailed t test.
RESULTS
Five control subjects (three male, two female; age range of 27-47 years) and five patients (two male, three female; age range of 36--64 years) par ticipated in the study.
Although all but one of the patients had been re garded as being free of evidence of encephalopathy at the time of the study, according to progress notes recorded in the medical record and personal con tacts with the physicians responsible for their care, all exhibited subtle signs of cerebral dysfunction that included mild lethargy and at least one of the following signs or symptoms: dysarthria, brisk deep tendon reflexes, or increased resistance to passive arm movement.
Whole-slice CBF values were 0.58 ± 0. 12 ml g-I min -I in the controls and 0.46 ± 0. 16 ml g-I min-I in the patients, a difference that was not significant.
A detailed analysis of regional CBF data from these and other subjects is presented in an accompanying article (Lockwood et aI., 199 1).
The arterial pH, ammonia concentration, and val ues for rCBF, rCMRA, E, and the aPS product from the normal controls and patients with liver disease are shown in Table 1 . Figure 1 shows images of rCBF, rCMRA, and aPS product images from a normal subject and cor responding images from a patient, scaled to reflect values relative to those in the normal subject. 
DISCUSSION
In a prior study that used a rectilinear scanner to measure brain isotope content, Lockwood et al. (1979) found an increase in the cerebral metabolic rate for ammonia in patients with mild hyperam monemia and encephalopathy. This study confirms this earlier finding utilizing PET, which provides a more accurate means of measuring tissue radioiso tope content. This strengthens the hypothesis that ammonia is of importance in the production of the encephalopathy associated with liver disease.
In this study, the arterial ammonia concentration in the patients was 83% higher than in controls (p < 0,0 1), while the CMRA was increased by a factor of 2. 6 (p < 0.025). In the earlier study (Lockwood et aI., 1979) , the arterial ammonia concentration in pa tients was 49% greater than control while the CMRA was increased by 66%. We sought evidence for factors causing this disproportionate increase in metabolism by measuring CBF and computing the fractional extraction of ammonia by the brain as well as the aPS product. Both of these computed variables are increased significantly, as shown in Table 1 . Our measured value for the aPS product in control subjects of 0. 13 ± 0.03 ml g -I min -I is virtually identical to the monkey brain PS product for ammonia gas of 0. 12 ± 0.02 ml g-I min-I re ported by Raichle and Larson (198 1).
In aqueous solutions at physiological pH values, about 99% of all ammonia exists as a diffusible gas, with the remainder present as the less mobile charged ammonium ion. Unless otherwise speci fied, in this report we have used "ammonia" to refer to the sum of the ionic and gaseous forms. As the pH of the blood is altered, the ratio of gaseous to ionic ammonia will change. Since the blood brain barrier is about 200 times more permeable to the gas than the ion (Raichle and Larson, 198 1), the single-pass extraction of ammonia as it moves through the cerebral vasculature is pH dependent.
Based on data obtained from the study of rats (Lockwood et aI., 1980) , in which a linear pH ex traction relationship was demonstrated throughout the pH range encountered in the present study, we attribute 20% of the difference in extraction we re port to differences in pH between the groups. Since the magnitude of the difference in extraction be tween groups was large, relative to the standard deviation, and the p value of �0.00 1 was small, it appears likely that there is a significant non-pH re sidual factor. This may be an increase in the true PS product of the barrier. Although we have studied a small number of pa tients with minimal evidence for encephalopathy, we believe that a significant increase in ammonia extraction by the brain and the aPS product may have clinical implications. Exogenous ammonia is clearly detrimental to brain function, and it must cross the blood-brain barrier and enter the brain to exert its effect. An increase in the PS product would CBF CMRA PS
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FIG. 1. Images of CBF, the CMRA, and the aPS product from a normal subject with an arterial ammonia concentration of 26 fLmol/L are shown in the first row. The respective whole-slice values are 0.49 ± 0.14 ml g-1 min-1, 0.312 ± 0.059 fLmol100 g-1 min 1, and 0.138 ± 0.025 ml 9 -1 min -1. Equivalent images from a subject with liver disease and an arterial ammonia concen tration of 66 fLmol/L are shown in the second row. The respective whole-slice values are 0.57 ± 0.13 ml 9-1 min-1, 1. 42 ± 0.23 fLmol100 g.1 min 1, and 0.272 ± 0.042 ml g-1 min-1.
allow ammonia to enter the brain more readily.
Thus, the effects of ammonia on the brain at a given arterial concentration will be increased in patients with an elevated ammonia PS product. This may explain why some patients with normal or near normal ammonia levels are encephalopathic, a find ing that has been cited as a weakness in the hypoth esis that ammonia causes hepatic encephalopathy.
It would follow that these patients may benefit from therapy designed to lower arterial ammonia levels.
